These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22443539)

  • 1. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).
    Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y
    Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
    Qi J; Lu Y; Wu W
    Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.
    Ali H; Singh SK
    Ther Deliv; 2016 Oct; 7(10):691-709. PubMed ID: 27790956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
    Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
    Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
    Wang F; Cao J; Hao J; Liu K
    J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
    Khatak S; Dureja H
    Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.
    Nunes S; Madureira AR; Campos D; Sarmento B; Gomes AM; Pintado M; Reis F
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1863-1873. PubMed ID: 26192708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.
    B A; D N; Veerabrahma K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
    Ravi PR; Vats R; Dalal V; Murthy AN
    J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.
    Hu X; Fan W; Yu Z; Lu Y; Qi J; Zhang J; Dong X; Zhao W; Wu W
    Nanoscale; 2016 Apr; 8(13):7024-35. PubMed ID: 26725649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
    Ramalingam P; Ko YT
    Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of levosulpiride-loaded solid lipid nanoparticles and their
    Khaleeq N; Din FU; Khan AS; Rabia S; Dar J; Khan GM
    J Microencapsul; 2020 Mar; 37(2):160-169. PubMed ID: 31916886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
    Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
    J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.